Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database

Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database

Objective: This study aims to explore the risk signals of osteonecrosis of the jaw induced by antiresorptive drugs and provide references for the clinical safety application.Method: According to the FDA’s Adverse Event Reporting System (FAERS), from January 2004 to September 2021, we chose “Osteonec...

Full description

Bibliographic Details
Main Authors: Jing Peng, Hui Wang, Zhen Liu, Zhen-Liang Xu, Mei-Xia Wang, Qi-Miao Chen, Ming-Li Wu, Xiao-Lei Ren, Qiu-Hua Liang, Fu-Peng Liu, Bo Ban
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Pharmacology
Subjects:
antiresorptive drugs
osteonecrosis of jaw
romosozumab
the US food and drug administration adverse event reporting system
database
signal processing
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1017391/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.1017391/full

Similar Items